Filing Details

Accession Number:
0001274225-18-000011
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-08 17:37:06
Reporting Period:
2018-06-06
Accepted Time:
2018-06-08 17:37:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899923 Myriad Genetics Inc MYGN In Vitro & In Vivo Diagnostic Substances (2835) 870494517
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274225 Dennis Langer 320 Wakara Way
Salt Lake City UT 84108
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-06 3,609 $21.29 43,352 No 4 M Direct
Common Stock Disposition 2018-06-06 3,609 $39.37 39,743 No 4 S Direct
Common Stock Acquisiton 2018-06-07 3,096 $21.29 42,839 No 4 M Direct
Common Stock Disposition 2018-06-07 3,096 $39.35 39,743 No 4 S Direct
Common Stock Acquisiton 2018-06-08 13,664 $21.29 53,407 No 4 M Direct
Common Stock Disposition 2018-06-08 13,664 $39.35 39,743 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-06-06 3,609 $0.00 3,609 $21.29
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-06-07 3,096 $0.00 3,096 $21.29
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2018-06-08 13,664 $0.00 13,664 $21.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,760 2012-12-02 2021-12-02 No 4 M Direct
13,664 2012-12-02 2021-12-02 No 4 M Direct
0 2012-12-02 2021-12-02 No 4 M Direct